Page last updated: 2024-09-05

sb 203580 and pd 153035

sb 203580 has been researched along with pd 153035 in 9 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(pd 153035)
Trials
(pd 153035)
Recent Studies (post-2010) (pd 153035)
3,48941,137232261

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)pd 153035 (IC50)
Cyclin-G-associated kinaseHomo sapiens (human)0.26
Mitogen-activated protein kinase 13Homo sapiens (human)6.3
Dihydrofolate reductaseHomo sapiens (human)0.2
Dihydrofolate reductaseMus musculus (house mouse)0.2
Tyrosine-protein kinase ABL1Homo sapiens (human)0.03
Tyrosine-protein kinase transforming protein AblAbelson murine leukemia virus0.4787
Epidermal growth factor receptorHomo sapiens (human)0.1416
Protein kinase C alpha typeBos taurus (cattle)0.4787
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)2.735
Cyclin-dependent kinase 1Homo sapiens (human)0.4787
Fructose-1,6-bisphosphatase 1Homo sapiens (human)1
Platelet-derived growth factor receptor betaHomo sapiens (human)0.2
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.709
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.4787
Dihydrofolate reductasePneumocystis carinii0.2
Potassium-transporting ATPase subunit betaSus scrofa (pig)0.03
Potassium-transporting ATPase alpha chain 1Sus scrofa (pig)0.03
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.8445
Mitogen-activated protein kinase 12Homo sapiens (human)6.3
Mitogen-activated protein kinase 11Homo sapiens (human)6.3
Mitogen-activated protein kinase 14Homo sapiens (human)6.3
Dihydrofolate reductaseRattus norvegicus (Norway rat)0.2
MAP kinase-interacting serine/threonine-protein kinase 1Homo sapiens (human)0.63
Histamine H3 receptorRattus norvegicus (Norway rat)1
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)2.025

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, JR; Deretey, E; Foster, JE; Ng, W; Pasternak, A; Redden, PR; Reid, N; Slon-Usakiewicz, JJ; Toledo-Sherman, L2
Dai, JR; Deretey, E; Foster, JE; Liao, LC; Ng, W; Pasternak, A; Redden, PR; Reid, N; Slon-Usakiewicz, JJ; Toledo-Sherman, L; Uger, MD1
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Buresi, MC; Buret, AG; Hollenberg, MD; MacNaughton, WK1
Chakraborty, C; Lala, PK; Timoshenko, AV; Wagner, GF1
Kawakami, T; Olsson, T; Yucel-Lindberg, T1
Kawanishi, M; Koizumi, K; Nishimura, M; Saiki, I; Sakurai, H; Shin, MS; Singhirunnusorn, P; Suzuki, S1

Other Studies

9 other study(ies) available for sb 203580 and pd 153035

ArticleYear
Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
    Journal of medicinal chemistry, 2004, Oct-07, Volume: 47, Issue:21

    Topics: Chromatography, Affinity; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Ligands; Mass Spectrometry; Models, Molecular; Receptor, EphB2

2004
Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Chromatography, Affinity; Databases, Factual; Enzyme-Linked Immunosorbent Assay; Heterocyclic Compounds; Humans; Mass Spectrometry; Models, Molecular; Molecular Weight; Naphthoquinones; Phosphorylation; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Receptor, EphB2; Sulfides

2005
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Activation of proteinase-activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase- and cyclo-oxygenase-dependent pathway.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:12

    Topics: Androstadienes; Butadienes; Cell Line; Chlorides; Epithelial Cells; Humans; Imidazoles; Indoles; Maleimides; Mitogen-Activated Protein Kinases; Nitriles; Nitrobenzenes; Phospholipases A; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Pyridines; Pyrimidines; Quinazolines; Receptor, PAR-1; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Tyrphostins; Wortmannin

2002
Global kinase screening. Applications of frontal affinity chromatography coupled to mass spectrometry in drug discovery.
    Analytical chemistry, 2005, Mar-01, Volume: 77, Issue:5

    Topics: Alkaloids; Animals; Benzophenanthridines; Binding Sites; Binding, Competitive; Catalytic Domain; Chromatography, Affinity; Drug Evaluation, Preclinical; Humans; Imidazoles; Mass Spectrometry; Mice; Molecular Structure; Peptides; Phosphorylation; Protein Binding; Protein Kinase C-alpha; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Quinazolines; Receptor, EphB2; Recombinant Proteins

2005
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer.
    British journal of cancer, 2006, Apr-24, Volume: 94, Issue:8

    Topics: Breast Neoplasms; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Down-Regulation; Enzyme Activation; Female; Glycoproteins; Humans; Imidazoles; Lymphangiogenesis; Molecular Sequence Data; Pyrazoles; Pyridines; Pyrimidines; Quinazolines; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; RNA, Small Interfering; Structure-Activity Relationship; Vascular Endothelial Growth Factor C; Vesicular Transport Proteins

2006
Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts.
    Cellular signalling, 2006, Volume: 18, Issue:12

    Topics: Arachidonic Acid; Blotting, Western; Cells, Cultured; Child; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Regulation; Gingiva; Humans; Imidazoles; Indoles; Interleukin-1beta; Intramolecular Oxidoreductases; Maleimides; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Prostaglandin D2; Prostaglandin-E Synthases; Protein Kinase C; Protein-Tyrosine Kinases; Pyridines; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha

2006
TAK1-mediated serine/threonine phosphorylation of epidermal growth factor receptor via p38/extracellular signal-regulated kinase: NF-{kappa}B-independent survival pathways in tumor necrosis factor alpha signaling.
    Molecular and cellular biology, 2009, Volume: 29, Issue:20

    Topics: Anthracenes; Butadienes; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; HeLa Cells; Humans; Imidazoles; Lactones; MAP Kinase Kinase Kinases; NF-kappa B; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinazolines; Resorcinols; RNA, Small Interfering; Serine; Signal Transduction; Threonine; Tumor Necrosis Factor-alpha

2009